Wegovy

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read
Photo by News Øresund – Johan Wessman via CC BY 2.0

Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read

Photo illustration by Connor Lin / The Daily Upside, Photo by Marcio Silva via iStock

Economics

Wall Street’s New Year’s Resolution: Launch More IPOs

No matter how you cast your ballot in the presidential election last month, recent history suggests your vote counts for IPOs.

6 min read
Photo by Daniel X. O’Neil via CC BY 2.0

Industries

Posh Soho House Gets Premium Buyout Offer as It Balances Prestige with Scaling Up

The offer would put an 83% premium on Soho’s Wednesday closing price and comes a year after it had to close off admissions in three cities.

2 min read
Photo via Oura

Technology

Smart Ring Maker Oura Doubles Valuation to $5.2 billion

One ring to rule them all… at least, Oura hopes so. On Thursday, it announced a new $200 million funding round.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.